Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lankester

Showing results (131-140 of 207) with videos related to

Pageof 21
Sort By:
The Journal of Infectious Diseases|January 19, 2005
Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipientsBianca Heemskerk, Arjan C Lankester, Tamara van Vreeswijk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantationGertjan Lugthart, Monique M van Ostaijen-Ten Dam, Cornelia M Jol-van der Zijde, et al.
European Journal of Endocrinology|January 5, 2012
A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activationD Mul, S Wu, R A de Paus, et al.
British Journal of Haematology|October 20, 2017
High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre studyM Y Eileen C van der Stoep, Alice Bertaina, Marloes H Ten Brink, et al.
Kidney International|June 8, 2021
Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantationGertjan Lugthart, Carlijn C E Jordans, Anne P J de Pagter, et al.
Clinical Pharmacokinetics|May 28, 2019
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve OutcomeRick Admiraal, Cornelia M Jol-van der Zijde, Juliana M Furtado Silva, et al.
European Journal of Haematology|August 8, 2018
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision modelFrederick W Thielen, Hedwig M Blommestein, Liesbeth E M Oosten, et al.
British Journal of Haematology|April 19, 2017
Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detectionPrisca M J Theunissen, Lukasz Sedek, Valerie De Haas, et al.
Biochimica Et Biophysica Acta. General Subjects|January 16, 2026
Rapid in vivo loss of non-T-cell binding capacities of ATLG Grafalon® and ATG Thymoglobulin® explains selective effect on T-cell reconstitution after hematopoietic stem cell transplantationLisa V E Oostenbrink, Anja M Jansen-Hoogendijk, Monique M van Ostaijen-Ten Dam, et al.
Bone Marrow Transplantation|February 24, 2021
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 yearsJakob R Passweg, Helen Baldomero, Christian Chabannon, et al.
Pageof 21

Showing results (131-140 of 207) with videos related to

Sort By:
Pageof 21
The Journal of Infectious Diseases|January 19, 2005
Immune reconstitution and clearance of human adenovirus viremia in pediatric stem-cell recipientsBianca Heemskerk, Arjan C Lankester, Tamara van Vreeswijk, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Early cytomegalovirus reactivation leaves a specific and dynamic imprint on the reconstituting T cell compartment long-term after hematopoietic stem cell transplantationGertjan Lugthart, Monique M van Ostaijen-Ten Dam, Cornelia M Jol-van der Zijde, et al.
European Journal of Endocrinology|January 5, 2012
A mosaic de novo duplication of 17q21-25 is associated with GH insensitivity, disturbed in vitro CD28-mediated signaling, and decreased STAT5B, PI3K, and NF-κB activationD Mul, S Wu, R A de Paus, et al.
British Journal of Haematology|October 20, 2017
High interpatient variability of treosulfan exposure is associated with early toxicity in paediatric HSCT: a prospective multicentre studyM Y Eileen C van der Stoep, Alice Bertaina, Marloes H Ten Brink, et al.
Kidney International|June 8, 2021
Chronic kidney disease ten years after pediatric allogeneic hematopoietic stem cell transplantationGertjan Lugthart, Carlijn C E Jordans, Anne P J de Pagter, et al.
Clinical Pharmacokinetics|May 28, 2019
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve OutcomeRick Admiraal, Cornelia M Jol-van der Zijde, Juliana M Furtado Silva, et al.
European Journal of Haematology|August 8, 2018
Second-line treatment for acute graft-versus-host disease with mesenchymal stromal cells: A decision modelFrederick W Thielen, Hedwig M Blommestein, Liesbeth E M Oosten, et al.
British Journal of Haematology|April 19, 2017
Detailed immunophenotyping of B-cell precursors in regenerating bone marrow of acute lymphoblastic leukaemia patients: implications for minimal residual disease detectionPrisca M J Theunissen, Lukasz Sedek, Valerie De Haas, et al.
Biochimica Et Biophysica Acta. General Subjects|January 16, 2026
Rapid in vivo loss of non-T-cell binding capacities of ATLG Grafalon® and ATG Thymoglobulin® explains selective effect on T-cell reconstitution after hematopoietic stem cell transplantationLisa V E Oostenbrink, Anja M Jansen-Hoogendijk, Monique M van Ostaijen-Ten Dam, et al.
Bone Marrow Transplantation|February 24, 2021
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 yearsJakob R Passweg, Helen Baldomero, Christian Chabannon, et al.
Pageof 21